Related Experiment Videos
Echocardiographic comparison between prenalterol and dobutamine.
Acta Medica Scandinavica. Supplementum
|January 1, 1982
Summary
Prenalterol, a selective beta 1-adrenoceptor agonist, offers a longer-lasting increase in heart contractility compared to dobutamine. Its minimal impact on blood pressure suggests targeted beta 1-receptor effects with fewer side effects.
Area of Science:
- Cardiology
- Pharmacology
- Physiology
Background:
- Cardioselective beta-1 adrenoceptor agonists represent a therapeutic advance.
- Dobutamine is a commonly used beta-stimulator for cardiac conditions.
Purpose of the Study:
- To compare the efficacy and selectivity of prenalterol with dobutamine.
- To evaluate the effects on cardiac contractility, heart rate, preload, and afterload.
Main Methods:
- Computer-assisted echocardiography was employed for detailed cardiac assessment.
- Hemodynamic parameters including heart rate, blood pressure, preload, and afterload were monitored.
Main Results:
- Prenalterol demonstrated a prolonged increase in cardiac contractility compared to dobutamine.
- Prenalterol induced a greater decrease in preload and a longer increase in heart rate.
- Minimal changes in blood pressure and afterload were observed with prenalterol, indicating selective beta-1 receptor activity.
Conclusions:
- Prenalterol exhibits a more sustained positive inotropic effect than dobutamine.
- The selective beta-1 receptor action of prenalterol suggests a favorable hemodynamic profile.